Skip to content
Screener

Common Stock at other companies

Abbott logo
AbbottABT
2.4B-90.5%
TFX
TeleflexTFX
$48.2M+0.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$3.12B
Stryker logo
StrykerSYK
$38M0.0%
Delcath Systems logo
Delcath SystemsDCTH
80M0.0%
AngioDynamics logo
AngioDynamicsANGO
$387K+0.5%

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$5.24B+5.8%
Enterprise value$5.57B+2.6%
P/E37.6×-4.0×
P/S3.4×-0.1×

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: Merit Medical Systems’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:23 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000856982-26-000025
LIABILITIES AND STOCKHOLDERS’ EQUITYMarch 31, 2026December 31, 2025
Commitments and contingencies
Stockholders' equity:
Preferred stock — 5,000 shares authorized; no shares issued as of March 31, 2026 and December 31, 2025
Common stock, no par value — 100,000 shares authorized; issued and outstanding as of March 31, 2026 - 59,655 and December 31, 2025 - 59,424769,271763,909
Retained earnings865,025824,030
Accumulated other comprehensive loss(7,568)(3,636)
Total stockholders’ equity1,626,7281,584,303
Total liabilities and stockholders’ equity$2,719,284$2,685,922

Item 1. Financial Statements (Unaudited)

FAQ

What is Merit Medical Systems's common stock?
Merit Medical Systems (MMSI) reported common stock of $769.27M in Q1 2026.
How has Merit Medical Systems's common stock changed year-over-year?
Merit Medical Systems's common stock increased by 7.1% year-over-year, from $718.11M to $769.27M.
What is the long-term trend for Merit Medical Systems's common stock?
Over 5 years (2020 to 2025), Merit Medical Systems's common stock has grown at a 4.7% compound annual growth rate (CAGR), from $606.22M to $763.91M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about Merit Medical Systems's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude